(4-(Ethylcarbamoyl)-3-fluorophenyl)boronic acid, 95.0%, 1g

5,6-Dichloropyridazin-4-amine, 95.0%, 1g

TERT-BUTYL 3-(5-ACETAMIDOISOTHIAZOL-3-YL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

(6-methoxybenzo[d][1,3]dioxol-5-yl)methanamine, 95.0%, 500mg

ETHYL 5-BROMO-1-ISOPROPYL-1H-PYRAZOLE-4-CARBOXYLATE, 95.0%, 100mg

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 10mg

1-Nitronaphthalene, 25g

4-Amino-N-(3-(trifluoromethyl)phenyl)benzamide, 95+%, 1g

3-benzylazetidine hydrochloride, 95.0%, 500mg

2,3-Dihydro-4-methoxy-1H-inden-2-amine, 98%, 250mg

2-(2-Methoxy-5-nitrophenoxy)acetic acid, 98%, 100mg

Zernike phase contrast kit with PLPH i Plan phase 10/20/S40/S100 oil immersion IOS objectives, rotating Zernike condenser, telescope and green filter

4-(Benzyloxy)-2-methylbenzoic acid, 95.0%, 5g